---
title: "Citius Pharmaceuticals GAAP EPS of -$0.34 misses by $0.09, revenue of $1.5M misses by $8.27M"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296058441.md"
description: "Citius Pharmaceuticals GAAP EPS of -$0.34 misses by $0.09, revenue of $1.5M misses by $8.27M"
datetime: "2026-08-17T05:16:44.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296058441.md)
  - [en](https://longbridge.com/en/news/296058441.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296058441.md)
generator: "portal-rs"
---

# Citius Pharmaceuticals GAAP EPS of -$0.34 misses by $0.09, revenue of $1.5M misses by $8.27M


### Related Stocks

- [CTXR.US](https://longbridge.com/en/quote/CTXR.US.md)

## Related News & Research

- [CTXR: LYMPHIR's launch shows strong early adoption and revenue growth, with broader impact expected in 2027](https://longbridge.com/en/news/299093690.md)
- [CEA Industries GAAP EPS of -$0.22](https://longbridge.com/en/news/298765617.md)
- [Clearmind Medicine Inc. GAAP EPS of -$0.57](https://longbridge.com/en/news/298641285.md)
- [Empire Q1 GAAP EPS of $1.04](https://longbridge.com/en/news/298612302.md)
- [Uranium Royalty Corp. GAAP EPS of $0.10, revenue of $51M](https://longbridge.com/en/news/298964013.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**